Aurora Cannabis Inc
ACBNasdaqCIK 1683541HealthcareFiscal year ends Mar 31
Revenue is not reported in this company’s XBRL financial statements.
Latest quarter: Q4 FY2025
Three months to Mar 31, 2025, against the same quarter a year earlier.
- Revenuenot reported (Revenue not reported)No year-earlier figure to compare
- Gross marginnot reported (Revenue not reported)No year-earlier figure to compare
- Operating marginnot reported (Revenue not reported)No year-earlier figure to compare
- Net marginnot reported (Revenue not reported)No year-earlier figure to compare
- Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
- Free cash flownot reported (Operating cash flow and Capital expenditure not reported)No year-earlier figure to compare
Last eight quarters
Full statements| Line item | Unit | Q4 FY20222022-06-30 | period not labelled2024-06-30 | period not labelled2024-09-30 | period not labelled2024-12-31 | Q4 FY20252025-03-31 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $ | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | |
| Gross margin | % | not reported (Gross profit and Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | |
| Operating margin | % | not reported (Operating income and Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | |
| Net margin | % | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | not reported (Revenue not reported) | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | 0.10Diluted EPS, period not labelled, three months to 2024-06-30CAD 0.10 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | |
| Free cash flow | $ | not reported (Operating cash flow and Capital expenditure not reported) | not reported (Operating cash flow and Capital expenditure not reported) | not reported (Operating cash flow and Capital expenditure not reported) | not reported (Operating cash flow and Capital expenditure not reported) | not reported (Operating cash flow and Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY20202020-06-30 | FY20212021-06-30 | FY20222022-06-30 | FY20242024-03-31 | FY20252025-03-31 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $m | 269Revenue, FY2020, twelve months to 2020-06-30CAD 268.7m. XBRL concept ifrs-full:Revenue. 40-F filed 2021-09-27, accession 0001683541-21-000003.Report this figure | 245Revenue, FY2021, twelve months to 2021-06-30CAD 245.3m. XBRL concept ifrs-full:Revenue. 40-F filed 2022-09-21, accession 0001683541-22-000002.Report this figure | 221Revenue, FY2022, twelve months to 2022-06-30CAD 221.3m. XBRL concept ifrs-full:Revenue. 40-F filed 2023-06-14, accession 0001683541-23-000007.Report this figure | 270Revenue, FY2024, twelve months to 2024-03-31CAD 269.6m. XBRL concept ifrs-full:RevenueFromContractsWithCustomers. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | 343Revenue, FY2025, twelve months to 2025-03-31CAD 343.3m. XBRL concept ifrs-full:RevenueFromContractsWithCustomers. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | |
| Gross margin | % | (7.4%)Gross margin, FY2020, twelve months to 2020-06-30. gross profit / revenueGross profit: −CAD 19.9m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2021-09-27, accession 0001683541-21-000003.Revenue: CAD 268.7m. XBRL concept ifrs-full:Revenue. 40-F filed 2021-09-27, accession 0001683541-21-000003.Report this figure | (8.8%)Gross margin, FY2021, twelve months to 2021-06-30. gross profit / revenueGross profit: −CAD 21.6m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2022-09-21, accession 0001683541-22-000002.Revenue: CAD 245.3m. XBRL concept ifrs-full:Revenue. 40-F filed 2022-09-21, accession 0001683541-22-000002.Report this figure | 9.6%Gross margin, FY2022, twelve months to 2022-06-30. gross profit / revenueGross profit: CAD 21.2m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2023-06-14, accession 0001683541-23-000007.Revenue: CAD 221.3m. XBRL concept ifrs-full:Revenue. 40-F filed 2023-06-14, accession 0001683541-23-000007.Report this figure | 48.9%Gross margin, FY2024, twelve months to 2024-03-31. gross profit / revenueGross profit: CAD 131.7m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2025-06-18, accession 0001683541-25-000008.Revenue: CAD 269.6m. XBRL concept ifrs-full:RevenueFromContractsWithCustomers. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | 54.6%Gross margin, FY2025, twelve months to 2025-03-31. gross profit / revenueGross profit: CAD 187.6m. XBRL concept ifrs-full:GrossProfit. 40-F filed 2025-06-18, accession 0001683541-25-000008.Revenue: CAD 343.3m. XBRL concept ifrs-full:RevenueFromContractsWithCustomers. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | |
| Operating margin | % | (173.3%)Operating margin, FY2020, twelve months to 2020-06-30. operating income / revenueOperating income: −CAD 465.8m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2021-09-27, accession 0001683541-21-000003.Revenue: CAD 268.7m. XBRL concept ifrs-full:Revenue. 40-F filed 2021-09-27, accession 0001683541-21-000003.Report this figure | (115.3%)Operating margin, FY2021, twelve months to 2021-06-30. operating income / revenueOperating income: −CAD 282.8m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2022-09-21, accession 0001683541-22-000002.Revenue: CAD 245.3m. XBRL concept ifrs-full:Revenue. 40-F filed 2022-09-21, accession 0001683541-22-000002.Report this figure | (104.6%)Operating margin, FY2022, twelve months to 2022-06-30. operating income / revenueOperating income: −CAD 231.4m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2023-06-14, accession 0001683541-23-000007.Revenue: CAD 221.3m. XBRL concept ifrs-full:Revenue. 40-F filed 2023-06-14, accession 0001683541-23-000007.Report this figure | (16.7%)Operating margin, FY2024, twelve months to 2024-03-31. operating income / revenueOperating income: −CAD 45.1m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2025-06-18, accession 0001683541-25-000008.Revenue: CAD 269.6m. XBRL concept ifrs-full:RevenueFromContractsWithCustomers. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | 1.4%Operating margin, FY2025, twelve months to 2025-03-31. operating income / revenueOperating income: CAD 4.9m. XBRL concept ifrs-full:ProfitLossFromOperatingActivities. 40-F filed 2025-06-18, accession 0001683541-25-000008.Revenue: CAD 343.3m. XBRL concept ifrs-full:RevenueFromContractsWithCustomers. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | |
| Net margin | % | (1221.7%)Net margin, FY2020, twelve months to 2020-06-30. net income / revenueNet income: −CAD 3.28bn. XBRL concept ifrs-full:ProfitLossAttributableToOwnersOfParent. 40-F filed 2021-09-27, accession 0001683541-21-000003.Revenue: CAD 268.7m. XBRL concept ifrs-full:Revenue. 40-F filed 2021-09-27, accession 0001683541-21-000003.Report this figure | (282.2%)Net margin, FY2021, twelve months to 2021-06-30. net income / revenueNet income: −CAD 692.0m. XBRL concept ifrs-full:ProfitLossAttributableToOwnersOfParent. 40-F filed 2022-09-21, accession 0001683541-22-000002.Revenue: CAD 245.3m. XBRL concept ifrs-full:Revenue. 40-F filed 2022-09-21, accession 0001683541-22-000002.Report this figure | (776.0%)Net margin, FY2022, twelve months to 2022-06-30. net income / revenueNet income: −CAD 1.72bn. XBRL concept ifrs-full:ProfitLossAttributableToOwnersOfParent. 40-F filed 2022-09-21, accession 0001683541-22-000002.Revenue: CAD 221.3m. XBRL concept ifrs-full:Revenue. 40-F filed 2023-06-14, accession 0001683541-23-000007.Report this figure | (25.7%)Net margin, FY2024, twelve months to 2024-03-31. net income / revenueNet income: −CAD 69.3m. XBRL concept ifrs-full:ProfitLoss. 40-F filed 2025-06-18, accession 0001683541-25-000008.Revenue: CAD 269.6m. XBRL concept ifrs-full:RevenueFromContractsWithCustomers. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | 0.5%Net margin, FY2025, twelve months to 2025-03-31. net income / revenueNet income: CAD 1.6m. XBRL concept ifrs-full:ProfitLoss. 40-F filed 2025-06-18, accession 0001683541-25-000008.Revenue: CAD 343.3m. XBRL concept ifrs-full:RevenueFromContractsWithCustomers. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | (4.10)Diluted EPS, FY2021, twelve months to 2021-06-30−CAD 4.10 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2022-09-21, accession 0001683541-22-000002.Report this figure | (7.99)Diluted EPS, FY2022, twelve months to 2022-06-30−CAD 7.99 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2022-09-21, accession 0001683541-22-000002.Report this figure | (1.52)Diluted EPS, FY2024, twelve months to 2024-03-31−CAD 1.52 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | 0.04Diluted EPS, FY2025, twelve months to 2025-03-31CAD 0.04 per share. XBRL concept ifrs-full:DilutedEarningsLossPerShare. 40-F filed 2025-06-18, accession 0001683541-25-000008.Report this figure | |
| Free cash flow | $m | not reported (Capital expenditure not reported) | (264)Free cash flow, FY2021, twelve months to 2021-06-30. operating cash flow − capital expenditureOperating cash flow: −CAD 210.6m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 40-F filed 2022-09-21, accession 0001683541-22-000002.Capital expenditure: CAD 53.1m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 40-F filed 2022-09-21, accession 0001683541-22-000002.Report this figure | (142)Free cash flow, FY2022, twelve months to 2022-06-30. operating cash flow − capital expenditureOperating cash flow: −CAD 110.3m. XBRL concept ifrs-full:CashFlowsFromUsedInOperatingActivities. 40-F filed 2023-06-14, accession 0001683541-23-000007.Capital expenditure: CAD 32.2m. XBRL concept ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. 40-F filed 2023-06-14, accession 0001683541-23-000007.Report this figure | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 2026-06-30 | $3.8m | 1,350,837 | Added+294,619 | |
| Tidal Investments LLC | 2026-06-30 | $3.5m | 1,264,494 | Added+14,827 | |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $2.2m | 784,955 | Added+26,774 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-06-30 | $807.7k | 289,500 | Call | Reduced−48,900 |
| NATIONAL BANK OF CANADA /FI/ | 2026-06-30 | $672.5k | 241,055 | Reduced−30,235 | |
| MORGAN STANLEY | 2026-06-30 | $671.5k | 240,698 | Reduced−18,357 | |
| CITADEL ADVISORS LLC | 2026-06-30 | $523.7k | 187,700 | Put | Added+55,100 |
| CITADEL ADVISORS LLC | 2026-06-30 | $513.6k | 184,100 | Call | Reduced−40,000 |
| UBS Group AG | 2026-06-30 | $495.4k | 177,561 | Added+25,293 | |
| AdvisorShares Investments LLC | 2026-06-30 | $477.4k | 171,110 | Unchanged |
Recent filings
All 428 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2907:18 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-29 | 0001104659-26-119872 |
| 2026-10-2609:30 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-26 | 0001279569-26-001004 |
| 2026-10-1416:18 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-14 | 0001279569-26-000974 |
| 2026-10-0808:16 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-08 | 0001279569-26-000960 |
| 2026-10-0717:35 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-06 | 0001279569-26-000955 |
| 2026-10-0618:41 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-05 | 0001279569-26-000950 |
| 2026-09-2419:38 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-23 | 0001279569-26-000915 |
| 2026-09-1607:24 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-16 | 0001279569-26-000887 |
| 2026-09-1414:28 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-14 | 0001279569-26-000881 |
| 2026-09-0907:39 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-09 | 0001279569-26-000865 |
Latest annual report
Form 40-F for the fiscal year ended Mar 31, 2026Filed Jun 11, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league
About the filer
- CIK
- 1683541
- Tickers
- ACB
- Exchange
- Nasdaq
- SIC code
- 2833 Medicinal Chemicals & Botanical Products
- Sector
- Healthcare
- Fiscal year ends
- Mar 31
- Incorporated in
- A1
- Filer category
- <br>Emerging growth company
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 07:19 ET. Listed shows no prices and gives no investment advice.